Icao, Marilou I.
HRN: 10-91-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2023
CEFTRIAXONE 1G (VIAL)
12/22/2023
12/29/2023
IV
2g
Q24H
PMBO
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes